4221 North 203rd Street Suite 100,
Elkhorn , NE, 68130

Rank

Rank Universe
59 60

Summary

The fund seeks capital appreciation in the long term by investing in companies across any size in the United States.

The investment process is relies on fundamental analysis to identify companies in healthcare and life sciences companies.

Healthcare and life sciences companies include those companies that derive or are expected to derive 50% or more of their revenue from healthcare and life science products and services inc More

Link

Directors

Sep 13, 2023
  • Stephen P. Lachenauer
  • Jerry Szilagyi
  • Tobias Caldwell
  • Tiberiu Weisz

Chief Compliance Officer

  • Frederick J. Schmidt

Fund Manager(s)

Price

  • $ 33.8 ( +0.54 )
    Jan 2, 2025
    Last Close
  • Net Assets
  • $1.7B
    Feb 29, 2024
  • Holding
  • 95
    Aug 29, 2024
    More

  • 52-Week High/Low
  • $40.29 - $32.99
  • Turnover
  • 62%
  • Expense Ratio
  • 1.31%

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

1.38%

5 Year

-19.24%

Best

61.81%

2013

Worst

-25.23%

2021

Alpha

ETIHX S&P 500

Chart +